Drug Discovery Informatics Market to Reach US$15.1 Bn by 2036 as AI and Data-Driven R&D Reshape Drug Development

The global drug discovery informatics market is entering a high-growth phase as pharmaceutical and biotechnology companies increasingly shift from conventional research workflows toward computational, data-driven drug development. The industry was valued at US$4.8 Bn in 2025 and is estimated to advance at a 10.8% CAGR from 2026 to 2036, reaching approximately US$15.1 Bn by the end of 2036.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=33713

Drug discovery informatics combines software, databases, bioinformatics, artificial intelligence (AI), machine learning (ML), molecular modeling, and advanced analytics to help researchers identify targets, screen compounds, generate leads, and predict drug characteristics. The technology is becoming strategically important as drug pipelines grow more complex and pharmaceutical companies seek greater R&D productivity.

Market Overview

Drug discovery is a lengthy and resource-intensive process involving target identification, compound screening, lead optimization, preclinical testing, and clinical development. Informatics platforms help researchers manage and analyze large volumes of chemical, biological, genomic, proteomic, toxicological, and clinical information.

Growing digitalization is also creating demand for integrated platforms capable of connecting previously fragmented datasets. Better data organization and interoperability can support AI applications across target identification, molecular design, virtual screening, toxicity prediction, and biomarker discovery.

The market is therefore evolving beyond traditional databases and laboratory software toward intelligent platforms that combine scientific data with predictive models and automated workflows.

Key Drivers of Market Growth

Rising Pharmaceutical R&D Investment
Increasing investment in pharmaceutical research is a fundamental growth driver. Global pharmaceutical R&D spending reached approximately US$306 Bn in 2024, according to figures attributed to Evaluate Pharma, and is projected to approach US$366 Bn by 2030.

As R&D budgets expand, pharmaceutical companies are investing in digital infrastructure designed to improve the productivity of research programs. Informatics tools can support compound prioritization, data analysis, target validation, and decision-making across early-stage discovery.

Accelerating Adoption of AI and Machine Learning
AI and ML are transforming how researchers analyze scientific information and identify potential drug candidates. The 2026 Stanford AI Index reported approximately 80,150 AI-related publications in the natural sciences in 2025, representing a 26% increase from 2024. Life-science AI publications also increased substantially.

Generative AI is particularly important for molecular design, enabling researchers to explore chemical structures and prioritize candidates based on desired characteristics. However, experimental and clinical validation remains essential, creating demand for informatics systems that connect computational predictions with laboratory workflows.

Key Players and Industry Leaders

The competitive landscape includes technology providers, pharmaceutical informatics companies, computational drug discovery specialists, and contract research organizations. Prominent companies include Charles River Laboratories International, Thermo Fisher Scientific, Revvity, Dotmatics, Dassault Systèmes/BIOVIA, Insilico Medicine, Collaborative Drug Discovery, Schrödinger, Curia Global, and Certara.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/drug-discovery-informatics-market.html

Market Segmentation

The drug discovery informatics market can be segmented as follows:

By Product:
• Discovery Informatics
• Development Informatics

By Mode:
• In-house Informatics
• Outsourced Informatics

By Function:
• Sequencing and Target Data Analysis
• Docking
• Lead Generation Informatics
• Identification and Validation Informatics
• Molecular Modeling
• Others

By End-user:
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Others

By Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact:

Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY - 12207, United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453